Ireland[爱尔兰药品]

NEXIUM 40 mg TabletsEsomeprazole magnesium trihydrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-03-02 　查阅全文...

Ulcid 20 mg gastro-resistant capsulesOmeprazole

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-03-02 　查阅全文...

MULTAQ 400 mg film-coated tabletsDronedarone Hydrochloride

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-03-01 　查阅全文...

Zoladex LA 10.8 mg ImplantGoserelin Acetate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-03-01 　查阅全文...

Zoladex 3.6 mg ImplantGoserelin Acetate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-03-01 　查阅全文...

Firazyr 30 mg solution for injection in prefilled syringeIca

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-26 　查阅全文...

Iclusig 15mg and 45mg film-coated tablets

TableofContents 1.Nameofthemedicinalproduct 2.Qualitativeandquantitativecomposition 3.Pharmaceuticalform 4.Clinicalparticulars 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-02-25 　查阅全文...

Prograf 5 mg/ml concentrate for solution for infusion.Tacrol

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-25 　查阅全文...

Prograf 0.5 mg hard capsules.Tacrolimus Monohydrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-25 　查阅全文...

Prograf 1 mg hard capsules.Tacrolimus Monohydrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-25 　查阅全文...

Prograf 5 mg hard capsules.Tacrolimus Monohydrate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-25 　查阅全文...

Rasilez 150 mg film-coated tabletsAliskiren hemifumarate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-02-25 　查阅全文...

Rasilez HCT 150 mg/12.5 mg film-coated tabletsRasilez HCT 15

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-02-25 　查阅全文...

Rasilez 300 mg film-coated tabletsAliskiren hemifumarate

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-02-25 　查阅全文...

Inderal LA Prolonged-release Capsules 160mgPropranolol Hydro

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration..

录入者：admin 发表于：2014-02-23 　查阅全文...

Half -Inderal LA Prolonged-release Capsules 80mgPropranolol

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-23 　查阅全文...

Eucreas 50 mg/850 mg film-coated tabletsEucreas 50 mg/1000 m

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..

录入者：admin 发表于：2014-02-23 　查阅全文...

XGEVA 120 mg solution for injectionDenosumab

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-20 　查阅全文...

Erbitux 5 mg/ml solution for infusioncetuximab

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-19 　查阅全文...

Zometa 4 mg/5 ml concentrate for solution for infusionZoledr

TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..

录入者：admin 发表于：2014-02-18 　查阅全文...

首页上一页 53 54 55 56 57 58 59 下一页尾页 56/66/1301